5/8
07:34 am
kura
Kura Oncology to Participate in Bank of America Securities Healthcare Conference [Yahoo! Finance]
Low
Report
Kura Oncology to Participate in Bank of America Securities Healthcare Conference [Yahoo! Finance]
5/8
07:30 am
kura
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
Low
Report
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
5/6
11:55 am
kura
Kura Oncology, Inc. (NASDAQ: KURA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $32.00 price target on the stock.
Low
Report
Kura Oncology, Inc. (NASDAQ: KURA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $32.00 price target on the stock.
5/6
10:32 am
kura
Kura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Kura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/3
05:07 pm
kura
Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Low
Report
Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
5/3
09:57 am
kura
Kura Oncology, Inc. (NASDAQ: KURA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $37.00 price target on the stock.
Low
Report
Kura Oncology, Inc. (NASDAQ: KURA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $37.00 price target on the stock.
5/3
07:30 am
kura
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5/2
05:20 pm
kura
ARDX, TNDM and VIAV are among after hour movers [Seeking Alpha]
High
Report
ARDX, TNDM and VIAV are among after hour movers [Seeking Alpha]
5/2
04:13 pm
kura
Kura Oncology Reports First Quarter 2024 Financial Results [Yahoo! Finance]
High
Report
Kura Oncology Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/2
04:05 pm
kura
Kura Oncology Reports First Quarter 2024 Financial Results
Low
Report
Kura Oncology Reports First Quarter 2024 Financial Results
4/25
07:30 am
kura
Kura Oncology to Report First Quarter 2024 Financial Results
Medium
Report
Kura Oncology to Report First Quarter 2024 Financial Results
4/22
02:11 pm
kura
Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Medium
Report
Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
4/22
07:50 am
kura
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML [Yahoo! Finance]
Low
Report
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML [Yahoo! Finance]
4/22
07:30 am
kura
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
Low
Report
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
4/15
11:03 pm
kura
Kura Oncology, Inc. (NASDAQ: KURA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Kura Oncology, Inc. (NASDAQ: KURA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
4/10
07:39 am
kura
Kura Oncology to Participate in Stifel Targeted Oncology Forum [Yahoo! Finance]
Medium
Report
Kura Oncology to Participate in Stifel Targeted Oncology Forum [Yahoo! Finance]
4/10
07:30 am
kura
Kura Oncology to Participate in Stifel Targeted Oncology Forum
Medium
Report
Kura Oncology to Participate in Stifel Targeted Oncology Forum
4/5
07:30 am
kura
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Neutral
Report
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/3
11:01 pm
kura
Kura Oncology, Inc. (NASDAQ: KURA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Kura Oncology, Inc. (NASDAQ: KURA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/6
12:35 pm
kura
Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Low
Report
Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
3/6
07:38 am
kura
Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib in Renal Cell Carcinoma [Yahoo! Finance]
Medium
Report
Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib in Renal Cell Carcinoma [Yahoo! Finance]
3/6
07:30 am
kura
Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib in Renal Cell Carcinoma
Medium
Report
Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib in Renal Cell Carcinoma
3/1
05:00 pm
kura
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/28
02:29 pm
kura
Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Medium
Report
Kura Oncology, Inc. (NASDAQ: KURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
2/28
10:12 am
kura
Kura Oncology, Inc. (NASDAQ:KURA) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Kura Oncology, Inc. (NASDAQ:KURA) Q4 2023 Earnings Call Transcript [Yahoo! Finance]